White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression

被引:49
作者
Novak, Marianne J. U. [1 ,2 ]
Seunarine, Kiran K. [3 ]
Gibbard, Clare R. [3 ,4 ]
Hobbs, Nicola Z. [4 ]
Scahill, Rachael I. [4 ]
Clark, Chris A. [3 ]
Tabrizi, Sarah J. [1 ,4 ]
机构
[1] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[2] UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England
[3] UCL Inst Child Hlth, Imaging & Biophys Unit, London WC1N 1EH, England
[4] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England
基金
英国惠康基金;
关键词
Huntington's disease; Caudate; Diffusion; TBSS (tract-based spatial statistics); DTI (diffusion tensor imaging); CAG REPEAT LENGTH; CLINICAL PROGRESSION; HUMAN STRIATUM; DIFFUSION; PATHOLOGY; VOLUME;
D O I
10.1016/j.cortex.2013.11.009
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Introduction: Huntington's disease (HD) is associated with progressive loss of caudate and white matter volume and integrity. Our aim was to systematically assess interactions between these changes and genetic markers of disease progression; we are not aware of previous studies in which this has been explicitly tested. Methods: Tract-based spatial statistics were used to assess: (a) differences between the white matter diffusion metrics (fractional anisotropy and mean diffusivity) of 17 premanifest and 19 early manifest HD gene carriers and 21 controls, and (b) the relationships between diffusion metrics, caudate and total white matter volume, and disease burden score and CAG repeat length. Caudate and total white matter volumes were quantified using FIRST and SIENAX respectively. Multiple regression analysis was used to assess which of the imaging metrics predicted disease severity in the HD subjects. Results: Diffusion metrics were significantly altered in premanifest and early HD gene carriers in comparison with controls throughout the white matter skeleton. Correlations between diffusion and volumetric metrics and disease progression were also present. Together, caudate volume and mean white matter fractional anisotropy and mean diffusivity predicted disease burden score in the HD subjects. Conclusions: The diffusion properties of white matter are extensively altered in HD, and are associated with markers of HD severity, and with caudate and white matter volumes. The correlation between diffusion metrics and white matter volume is stronger in HD subjects than in controls, but there is no such significant interaction for the correlation between diffusion and caudate volume: we propose that many of the changes in white matter diffusion in HD occur as a 'normal' physiological response to pathological caudate volume loss. We have defined the extent to which mean white matter fractional anisotropy, white matter volume and caudate volume are associated with disease burden score. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:98 / 112
页数:15
相关论文
共 45 条
[31]   Accurate, robust, and automated longitudinal and cross-sectional brain change analysis [J].
Smith, SM ;
Zhang, YY ;
Jenkinson, M ;
Chen, J ;
Matthews, PM ;
Federico, A ;
De Stefano, N .
NEUROIMAGE, 2002, 17 (01) :479-489
[32]   Advances in functional and structural MR image analysis and implementation as FSL [J].
Smith, SM ;
Jenkinson, M ;
Woolrich, MW ;
Beckmann, CF ;
Behrens, TEJ ;
Johansen-Berg, H ;
Bannister, PR ;
De Luca, M ;
Drobnjak, I ;
Flitney, DE ;
Niazy, RK ;
Saunders, J ;
Vickers, J ;
Zhang, YY ;
De Stefano, N ;
Brady, JM ;
Matthews, PM .
NEUROIMAGE, 2004, 23 :S208-S219
[33]   Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data [J].
Smith, Stephen M. ;
Jenkinson, Mark ;
Johansen-Berg, Heidi ;
Rueckert, Daniel ;
Nichols, Thomas E. ;
Mackay, Clare E. ;
Watkins, Kate E. ;
Ciccarelli, Olga ;
Cader, M. Zaheer ;
Matthews, Paul M. ;
Behrens, Timothy E. J. .
NEUROIMAGE, 2006, 31 (04) :1487-1505
[34]   A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease [J].
Sritharan, Anusha ;
Egan, Gary F. ;
Johnston, Leigh ;
Horne, Malcolm ;
Bradshaw, John L. ;
Bohanna, India ;
Asadi, Hamed ;
Cunnington, Ross ;
Churchyard, Andrew J. ;
Chua, Phyllis ;
Farrow, Maree ;
Georgiou-Karistianis, Nellie .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (03) :257-262
[35]   Contrasting gray and white matter changes in preclinical Huntington disease An MRI study [J].
Stoffers, D. ;
Sheldon, S. ;
Kuperman, J. M. ;
Goldstein, J. ;
Corey-Bloom, J. ;
Aron, A. R. .
NEUROLOGY, 2010, 74 (15) :1208-1216
[36]   Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data [J].
Tabrizi, Sarah J. ;
Reilmann, Ralf ;
Roos, Raymund A. C. ;
Durr, Alexandra ;
Leavitt, Blair ;
Owen, Gail ;
Jones, Rebecca ;
Johnson, Hans ;
Craufurd, David ;
Hicks, Stephen L. ;
Kennard, Christopher ;
Landwehrmeyer, Bernhard ;
Stout, Julie C. ;
Borowsky, Beth ;
Scahill, Rachael I. ;
Frost, Chris ;
Langbehn, Douglas R. .
LANCET NEUROLOGY, 2012, 11 (01) :42-53
[37]   Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis [J].
Tabrizi, Sarah J. ;
Scahill, Rachael I. ;
Durr, Alexandra ;
Roos, Raymund A. C. ;
Leavitt, Blair R. ;
Jones, Rebecca ;
Landwehrmeyer, G. Bernhard ;
Fox, Nick C. ;
Johnson, Hans ;
Hicks, Stephen L. ;
Kennard, Christopher ;
Craufurd, David ;
Frost, Chris ;
Langbehn, Douglas R. ;
Reilmann, Ralf ;
Stout, Julie C. .
LANCET NEUROLOGY, 2011, 10 (01) :31-42
[38]   Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data [J].
Tabrizi, Sarah J. ;
Langbehn, Douglas R. ;
Leavitt, Blair R. ;
Roos, Raymund A. C. ;
Durr, Alexandra ;
Craufurd, David ;
Kennard, Christopher ;
Hicks, Stephen L. ;
Fox, Nick C. ;
Scahill, Rachael I. ;
Borowsky, Beth ;
Tobin, Allan J. ;
Rosas, H. Diana ;
Johnson, Hans ;
Reilmann, Ralf ;
Landwehrmeyer, Bernhard ;
Stout, Julie C. .
LANCET NEUROLOGY, 2009, 8 (09) :791-801
[39]   The distribution of structural neuropathology in pre-clinical Huntington's disease [J].
Thieben, M. J. ;
Duggins, A. J. ;
Good, C. D. ;
Gomes, L. ;
Mahant, N. ;
Richards, F. ;
McCusker, E. ;
Frackowiak, R. S. J. .
BRAIN, 2002, 125 :1815-1828
[40]  
Ulug AM, 1999, AM J NEURORADIOL, V20, P1044